Site (ICD-7) | Men | Women | ||||
---|---|---|---|---|---|---|
0–49 | 50–74 | 75+ | 0–49 | 50–74 | 75+ | |
*Excludes cancers and person-years during the first year after entry into cohort. | ||||||
All solid (140–199) | 182 (97 to 312) | 1633 (1510 to 1768) | 3239 (2996 to 3497) | 297 (232 to 375) | 1005 (945 to 1067) | 1346 (1261 to 1467) |
Colorectal (153–154) | 14 (0 to 78) | 137 (103 to 179) | 296 (226 to 381) | 29 (12 to 60) | 87 (71 to 108) | 184 (153 to 219) |
Hepatobiliary (155–156) | 0 (0 to 52) | 33 (18 to 56) | 74 (42 to 122) | 0 (0 to 15) | 31 (22 to 44) | 60 (43 to 81) |
Lung (162) | 0 (0 to 52) | 254 (207 to 310) | 271 (205 to 354) | 4. (0 to 23) | 105 (87 to 127) | 89 (68 to 115) |
Breast (170) | 0 (0 to 52) | 2.5 (0 to 14) | 4.9 (0.0 to 27) | 125 (85 to 180) | 267 (237 to 300) | 223 (190 to 262) |
Prostate (177) | 28 (3.4 to 102) | 493 (426 to 568) | 958 (827 to 1103) | – | – | – |
Melanoma (190) | 28 (3.4 to 102) | 33 (18 to 57) | 103 (64 to 159) | 37 (17 to 72) | 34 (24 to 48) | 55 (39 to 76) |
Non-melanoma skin (191) | 0 (0 to 52) | 152 (117 to 197) | 572 (473 to 687) | 4.2 (0 to 23) | 57 (44 to 74) | 197 (165 to 234) |